Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 16, 2019
Esophageal adenocarcinoma: when DNA methylation informs the treatment
from the Grady lab, Clinical Research Division
6 misconceptions about colorectal cancer
Get the facts and lower your risk
Exosomal microRNAs to predict colorectal cancer recurrence
From the Grady lab, Clinical Research Division
Less XIST to help Rett syndrome patients exist
From the Bedalov Lab, Clinical Research Division
Sleeping Beauty transposon is up and at ‘em for colorectal cancer study
From the Grady Lab (Clinical Research Division)
Fred Hutch researcher receives grant for esophageal cancer screening study
Incidence of esophageal cancer has increased fivefold since the 1970s
Glory's gift: Colon cancer patient's enduring legacy
A young woman’s resolve to help find a better way to detect colon cancer led to a years-long relationship between her family and a researcher across the country
Good News at Fred Hutch
Celebrating faculty and staff achievements
The bottom line on colon cancer: Get screened
March is National Colorectal Cancer Awareness Month
Tewari receives presidential award
Muneesh Tewari, honored for microRNA work, is among select recipients of the Presidential Early Career Award for Scientists and Engineers
Early detection efforts yield nearly $17 million
Awards fund network coordination and biomarker discovery, validation
PHS postdoc wins cancer prevention fellowship
Scott Adams to study effects of inflammatory conditions on colon cancer outcomes
Partnership for success
Emerging research programs, pediatric oncology, solid-tumor research areas are the focus of the Cancer Consortium's annual external review
Breaking cancer's family ties
SCCA's Gastrointestinal Cancer Prevention Program leads region in screening, counseling and treating people with high cancer risk
A comfortable colorectal test
Clinical researcher William Grady aims to improve colorectal-cancer survival by developing a screening test people are more likely to undergo